Acquired immune deficiency syndrome-related hyperkeratotic Kaposi's sarcoma with severe lymphoedema: Report of five cases

British Journal of Dermatology

Volumn 142, Issue 3, 2000, Pages 501-505

  Hengge, U R ^a   Stocks, K ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Acquired immune deficiency syndrome; Hyperkeratosis; Kaposi's sarcoma; Lymphoedema

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; ERYTHEMA; HUMAN; HYPERKERATOSIS; KAPOSI SARCOMA; LYMPHEDEMA; MALE; PRIORITY JOURNAL; SKIN DEFECT; SKIN NODULE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; KERATOSIS; LYMPHEDEMA; MALE; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 0034015003     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03364.x     Document Type: Article

References (18)

1. 1 Kaposi M. Idiopathisches multiples Pigment Sarcom der Haut. Dermatol Syphiligr 1872; 4: 265-72.
2. 2 Requena L, Sangueza OP. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms. J Am Acad Dermatol 1998; 38: 143-75.
3. 3 Ensoli B, Siranni MC. Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. Crit Rev Oncog 1998; 9: (2) 107-24.
4. 4 Chang Y, Cesarman E, Pessin MS et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
5. 5 Caputo R, Gianotti R, Grimalt R et al. Soft fibroma-like lesions on the legs of a patient with Kaposi's sarcoma and lymphedema. Am J Dermatopathol 1991; 13: 493-6.
6. 6 Frans E, Blockmanns D, Peetermans W et al. Kaposi's sarcoma presenting as generalized lymphedema. Acta Clin Belg 1994; 49: 119-22.
7. 7 Allen JA, Gillespie DL, Redfield RR, Gomez ER. Lower extremity lymphedema caused by acquired immune deficiency syndrome-related Kaposi's sarcoma: case report and review of the literature. J Vasc Surg 1995; 22: 178-81.
8. 8 Brodt HR, Kamps BS, Gute P et al. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997; 11: 1731-8.
9. 9 von Roenn JH, Krown SE. Management of AIDS-associated Kaposi's sarcoma: a multi-disciplinary perspective. Oncology 1998; 12: 1-24.
10. 10 Dorfman RF. Kaposi's sarcoma: evidence supporting its origin from the lymphatic system. Lymphology 1988; 21: 45-52.
11. 11 Stürzl M, Ensoli B. Big but weak: how many pathogenic genes does human herpesvirus-8 need to cause Kaposi's sarcoma? Int J Oncol 1999; 14: 287-9.
12. 12 Bais C, Santomasso B, Coso O et al. G-protein-coupled receptor of Kaposi's sarcoma associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998; 391: 86-9.
13. 13 Finch PW, Murphy F, Cardinale I, Krueger JG. Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol 1997; 151: 1619-28.
14. 14 Schmeller W, Hoos A. Verrucous elephantiasis: a maximum variant of lymphedema. Hautarzt 1989; 40: 276-80.
15. 15 Swift PS. The role of radiation therapy in the management of HIV-related Kaposi's sarcoma. Hematol Oncol Clin North Am 1996; 10: 1069-80.
16. 16 De Wit R, Schattenkerk JKME, Boucher CAB et al. Clinical and virological effects of high-dose recombinant interferon-α in disseminated AIDS-related Kaposi's sarcoma. Lancet 1988; 2: 1214-7.
17. 17 Hengge UR, Brockmeyer NH, Baumann M et al. Liposomal doxorubicin treatment of AIDS-related Kaposi's sarcoma. (Letter.) Lancet 1993; 342: 497.
18. 18 Coukell AJ, Spencer CM. Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. Drugs 1997; 53: 520-38.